A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ZN-c5|DRUG: Abemaciclib
Sponsor: Zeno Alpha Inc.